Development of Nanoparticles to Deliver a CRISPR/Cas9 Therapy for Duchenne Muscular Dystrophy

被引：0
|
作者：
Emami, Michael R. [1 ,2 ,3 ]
Young, Courtney S. [1 ,2 ,3 ]
Ji, Ying [4 ,5 ]
Pyle, April D. [1 ,2 ,6 ]
Meng, Huan [4 ,5 ]
Spencer, Melissa J. [1 ,2 ,3 ]
机构：
[1] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Ctr Duchenne Muscular Dystrophy, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Neurol, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA USA
[5] Univ Calif Los Angeles, Div Nanomed, Med, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Microbiol Immunol & Mol Genet, Los Angeles, CA USA
来源：
MOLECULAR THERAPY | 2018年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
615
引用
收藏
页码：284 / 285
页数：2
相关论文
共 50 条
  • [41] CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy
    Wilton-Clark, Harry
    Yokota, Toshifumi
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 500 - 501
  • [42] Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
    Lin, Yao
    Wu, Jiahua
    Gu, Weihuai
    Huang, Yulei
    Tong, Zhongchun
    Huang, Lijia
    Tan, Jiali
    ADVANCED SCIENCE, 2018, 5 (04):
  • [43] CRISPR therapy shows promise in Duchenne muscular dystrophy
    Charlotte Ridler
    Nature Reviews Neurology, 2018, 14 : 632 - 633
  • [44] CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
    Chemello, Francesco
    Olson, Eric N.
    Bassel-Duby, Rhonda
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 379 - 387
  • [45] CRISPR therapy shows promise in Duchenne muscular dystrophy
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2018, 14 (11) : 632 - 633
  • [46] Age-Dependent Echocardiographic and Pathologic Findings in a Rat Model with Duchenne Muscular Dystrophy Generated by CRISPR/Cas9 Genome Editing
    Sugihara, Hidetoshi
    Kimura, Koichi
    Yamanouchi, Keitaro
    Teramoto, Naomi
    Okano, Tomoko
    Daimon, Masao
    Morita, Hiroyuki
    Takenaka, Katsu
    Shiga, Takanori
    Tanihata, Jun
    Aoki, Yoshitsugu
    Inoue-Nagamura, Tokiko
    Yotsuyanagi, Hiroshi
    Komuro, Issei
    INTERNATIONAL HEART JOURNAL, 2020, 61 (06) : 1279 - 1284
  • [47] Dystrophinopathic subjects with a specific mega-deletion of exons 45-55 in the DMD gene, as a template for CRISPR/Cas9 therapy in Duchenne muscular dystrophy
    Poyatos-Garcia, J.
    Soblechero-Martin, P.
    Albiasu-Arteta, E.
    Arechavala-Gomeza, V.
    Vazquez-Manrique, R.
    Muelas, N.
    Marti, P.
    Gomis, C.
    Vilchez, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S151 - S152
  • [48] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [49] Correction of a common Duchenne muscular dystrophy mutation by CRISPR/Cas9 gene editing using homology-independent targeted integration
    Nicolau, S.
    Sarff, J.
    Vetter, T.
    Stephenson, A.
    Flanigan, K.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [50] CRISPR/CAS9 CORRECTS RETINAL DYSTROPHY IN RATS
    Graham, Dustin M.
    LAB ANIMAL, 2016, 45 (03) : 85 - 85
12345